Abstract: A refrigerator can include a cabinet for defining a space; a first display door for opening and closing the space, the first display door including a display panel configured to output content; a second door for opening and closing the space; and a controller configured to control the display panel of the first display door and the light sources in the second door. Also, the second door includes a front plate; a light guide plate configured to guide light to the front plate; and light sources configured to irradiate light to the light guide plate and when the light sources are turned on, the front plate is configured to emit light in a first color.

Abstract: A refrigerator can include a cabinet for defining a space; a first display door for opening and closing the space, the first display door including a display panel configured to output content; a second door for opening and closing the space; and a controller configured to control the display panel of the first display door and the light sources in the second door. Also, the second door includes a front plate; a light guide plate configured to guide light to the front plate; and light sources configured to irradiate light to the light guide plate and when the light sources are turned on, the front plate is configured to emit light in a first color.

Abstract: Provided are a system and method of automatically measuring spinal parameters. The system includes an image acquisitor configured to acquire an overall image of a spine and a parameter extractor configured to generate a learning model for extracting designated points from various spinal images and detecting relationships between the extracted points as angles, search for the designated points in the overall spinal image of the image acquisitor using the generated learning model, and check angular relationships between the points.

Abstract: The present disclosure relates to an advanced in vivo reprogramming system and a cell conversion method using same. The reprogramming system of the present disclosure comprises a start cell marker promoter, a pluripotency-maintaining gene protein, an amino acid isolation peptide, Cre recombinase, a target cell marker promoter, LoxP, and a gene encoding a fluorescent protein, does not require cell fixation in order to confirm cell conversion, enables real-time monitoring in a living cell state, and may be used both in vitro and in vivo. Therefore, the present disclosure is expected to be widely used in the biological and medical fields.

Abstract: The present invention relates to a pharmaceutical composition comprising (S)-2-(((4?-trifluoromethylbiphenyl-4-yl)methyl)amino)propanamide methanesulfonate or a pharmaceutically acceptable salt thereof as an effective ingredient for prevention or treatment of spinal cord injury.